Carcinoma in situ of the female breast. 10 Year follow-up results of a prospective nationwide study

Breast Cancer Research and Treatment

Volumn 62, Issue 3, 2000, Pages 197-210

  Ottesen, G L ^a   Graversen, H P ^a   Blichert Toft, M ^a   Christensen, I J ^a   Andersen, J A ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Breast; Breast conservation surgery; Carcinoma in situ; Prognostic factors

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST HYPERPLASIA; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMA IN SITU; CELL NUCLEUS; CLINICAL TRIAL; DENMARK; EXCISION; FEMALE; FOLLOW UP; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NECROSIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; DENMARK; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES;

EID: 0033754785     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006453915590     Document Type: Article

References (32)

1. Ductal carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group
2. Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group
3. The growth pattern of in situ carcinoma in the female breast
4. Carcinoma in situ of the breast: Correlation of histopathology to immunohistochemical markers and DNA ploidy
5. Borderline epithelial lesions of the breast
6. Consensus conference on the classification of ductal carcinoma in situ
7. Ten-year result comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast
8. Ductal carcinoma in situ treated with lumpectomy and irradiation: Histopathological analysis of 49 specimens with emphasis on risk and long term results
9. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)
10. Prognostic classification of breast ductal carcinoma-in situ
11. Noninvasive ductal carcinoma of the breast: The relevance of histologic categorization
12. Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone
13. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect on nuclear grade on local recurrence
14. Ductal carcinoma in situ: Controversies in diagnosis, biology, and treatment
15. The clinical significance of pre-invasive breast carcinoma
16. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy
17. The natural history of ductal carcinoma in situ. Implications for clinical decision making
18. Extent, distribution, and mammographic/histologic correlations of breast ductal carcinoma in situ
19. Microcalcifications associated with ductal carcinoma in situ: Mammographic-pathologic correlation
20. Three dimensional imaging of mammary ductal carcinoma in situ: Clinical implications
21. A prognostic index for ductal carcinoma in situ of the breast
22. Lobular carcinoma in situ. A histological study of 52 cases
23. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast
24. Lobular neoplasia. Long term risk of breast cancer and relation to other factors
25. Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease
26. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years
27. Lobular carcinoma in situ of the breast. Long-term followup
28. Pathologic findings from the National Surgical Adjuvant Breast (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ
29. Loss of heterozygosity in lobular carcinoma in situ of the breast
30. Loss of heterozygosity in ductal carcinoma in situ of the breast